Image

Impact of Infusion Line Change Frequency on Infectious Complications Related to Central Venous Catheters in the ICU - A Randomized Controlled Trial

Impact of Infusion Line Change Frequency on Infectious Complications Related to Central Venous Catheters in the ICU - A Randomized Controlled Trial

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

In the intensive care unit, patients' care and secure drugs administration require a central venous catheter. These invasive devices can lead to complications, particularly infections. Most preventive recommendations focus on catheter insertion, line handling, and dressings. Few recommendations adress catheter dwell time, which is certainly the main source of infection. Part of the prevention strategy is the regular and systematic replacement of infusion sets , as they may become contaminated during use, mainly through the hands of healthcare professionals. Prolonged use increases the risk of infection. Infusion lines changes involve disconnecting the old sets, discarding infusion devices containing drug residues, and replacing them with new sterile devices.

Current international guidelines recommend replacing these sets every 4 days, and the Center for Disease Control and Prevention recommends not exceeding 7 days. Replacing these devices requires the time of qualified nurses, numerous sterile medical devices, and medications. In addition to the intended effect on infection prevention, the procedure has impacts on workload and costs.

The objective of the study is to demonstrate that changing infusion set every 7 days does not increase the rate of central venous catheters related infections compared with changing infusion set every 4 days.

Eligibility

Inclusion criteria

  • Adult patient
  • Any ICU patient with a central venous catheter (inserted by venipuncture) in place for less than 72 hours and with an expected dwell time of at least 7 days
  • Patient affiliated with or covered by a social security system
  • Patient who has given verbal consent or written consent from a third party or in the event that the patient is unable to give consent.

Exclusion Criteria

  • Patient with a documented bloodstream infection at the time of inclusion
  • Patient whose central venous catheter has been in place for more than 72 hours
  • Patient with suspected catheter-related infection
  • Patient whose study catheter was inserted using a guidewire exchange
  • Patient previously enrolled in the study during the same ICU stay
  • Patient whose condition, according to the clinician, does not allow safe placement of a central venous catheter, such as:
    • Allergy to catheter material
    • Confirmed deep vein thrombosis at the time of insertion
    • Inflammatory skin disorder at the insertion site
  • Patient admitted for extensive burns
  • Inadequate understanding of the French language
  • Pregnant, breastfeeding, or postpartum woman
  • Person deprived of liberty by judicial or administrative decision
  • Person receiving involuntary psychiatric care
  • Person under legal guardianship or other legal protection measure

Study details
    Intensive Care (ICU)
    Central Venous Catheter Related Infections
    Critical Care Nursing
    Catheter-associated Bloodstream Infections (CLABSI)
    Nursing Workload

NCT07183592

University Hospital, Angers

27 June 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.